Nebivolol versus enalapril in essential hypertension: A long-term double-blind comparative trial

Acta Clinica Belgica

Volumn 54, Issue 1, 1999, Pages 19-25

  Van Nueten, L ^a   Nielsen, M Rishøj ^b   Vertommen, C ^a   Dupont, A G ^a   Robertson, J I S ^b  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b Janssen Research Foundation ^*

Author keywords

Acceptability; ACE inhibition; Beta blockade; Endothelium; Nitric oxide release

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENALAPRIL; NEBIVOLOL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; SYMPTOMATOLOGY;

EID: 0032971813     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Fitzgerald JD (Ed.). First International Nebivolol Investigators' Meeting. Drug Invest. 1991; 3(Suppl.1): 1-203.
2. Van de Water A, Janssens W, Van Nueten L et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent and selective β1-adrenergic antagonist. J Cardiovasc Pharmacol. 1988; 11: 552-563.
3. Pauwels PJ, Gommeren W, Van Lommen G, Janssen PAJ, Leysen JE. The receptor binding profile of the new antihypetensive agent nebivolol and its stereoisomers compared with various β1-adrenergic blockers. Mol Phannacol. 1988; 34: 843-851.
4. Janssens WJ, Van de Water A, Xhonneux R, Reneman RS, Van Nueten JM, Janssen PAJ. Nebivolol is devoid of intrinsic sympathomimetic activity. Eur J Pharmacol 1988, 159: 89-95.
5. Van de Water A, Xhonneux R, Reneman RS, Janssen PAJ. Cardiovascular effects of dl-nebivolol and its enantiomers - a comparison with those of atenolol. Eur J Pharmacol. 1988; 156: 95-103.
6. Gao Y, Nagao T, Bond RA, Janssens WJ, Vanhoutte PM. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol. 1991; 17: 964-969.
7. Cockroft JE, Chowienczijk PJ, Brett SE et al. Nebivolol vasodilates human forearm vasculature: Evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther. 1995; 274: 1067-1071.